A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC

NCT03085069 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Respiratory Tract Neoplasms Nec
Lung Disease
Respiratory Tract Disease
Neoplasm, Bronchial
Carcinoma, Bronchogenic

Interventions

BIOLOGICAL: SHR-1210

Sponsor

Jiangsu HengRui Medicine Co., Ltd.